Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Mylan Receives Approvals for Generic Versions of Hyzaar and Cozaar

By Pharmaceutical Processing | October 15, 2010

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals
Inc. received final approvals from the FDA
for its Abbreviated New Drug Applications (ANDAs) for the generic versions of
Hyzaar Tablets, 50 mg/12.5 mg and 100 mg/25 mg, and Cozaar Tablets, 25 mg, 50
mg and 100 mg, both antihypertensives.

 

Merck and Co. Inc.’s Hyzaar is known generically as
Losartan Potassium and Hydrochlorothiazide (HCTZ) Tablets and Merck Research Laboratories’
Cozaar is known generically as Losartan Potassium Tablets.

 

Losartan Potassium and HCTZ Tablets, 50 mg/12.5 mg and 100
mg/25 mg, had U.S. sales of
approximately $570 million and Losartan Potassium Tablets had U.S. sales of
approximately $940 million for the 12 months ending June 30, 2010, according to
IMS Health. Both products are available for immediate shipment. Mylan Pharmaceuticals
received final FDA approval and launched the 100 mg/12.5 mg strength of
Losartan Potassium and HCTZ Tablets on April 6, 2010.

 

 

Related Articles Read More >

FDA logo
Ultra Supplement announces recall for undeclared tadalafil
analyzing medical sample
Expert answers to nitrosamine impurity questions
Cardinal Health
Cardinal Health announces $124M settlement of investors’ opioid suit
FDA logo
FDA warns four companies over selling honey tainted with prescription drugs

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards